The NF-κB activation of microglia in the SN has been confirmed in MPTP-treated mice and monkeys and PD patients, and the role of NF-κB in the adaptive immune response of PD brain SN has been investigated [82–84]. Here, NFKB1 is linked to Parkinson disease.